Clinical Trial

University of Michigan COPD Identification Through Lung Cancer Screening Cohort Study - MAP2

Study acronym: MAP2
Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to obtain new knowledge regarding screening for COPD. This study will use a participant's cancer screening CT scans performed as part of routine health care among current and former smokers at risk for COPD to identify participants who have had a spirometry or will have a spirometry test as part of the study to verify COPD status.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-03-14.
Trial Details
NCT Number NCT07482475
Lead Sponsor University of Michigan
Collaborators: COPD Foundation
Conditions COPD (Chronic Obstructive Pulmonary Disease), Cancer Lung Screening, Smoking Cigarette
Enrollment 200 participants
Start Date 2025-07-15
Primary Completion 2026-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2026-03-25